Bifidobacterium infantis is a subspecies of the Bifidobacterium longum species. It is an inherited microbe, often being passed down from mother to child during child birth.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
CAT
Size
Price
Quantity
LBST-060FG
Product Information
Product Overview
Bifidobacterium infantis is a subspecies of the Bifidobacterium longum species. It is an inherited microbe, often being passed down from mother to child during child birth.
Target
Bifidobacterium
Genus
Bifidobacterium
Application
Study and research
Type Strain
Yes
Culture Medium
BBL
Culture Conditions
37°C; Anaerobic
Risk Group
1
Product Format
Freeze-dried
Packaging
Ampoule tube
Storage
-80°C
Shelf Life
6 years
Target Introduction
Introduction
Bifidobacterium are Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They wre originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS; Generally Recognised As Safe status.
Alternative Names
Bifidobacterium infantis Reuter
FAQs Customer Reviews Related Products
How should Bifidobacterium infantis be handled to maintain anaerobic conditions?
Bifidobacterium infantis should be handled using an anaerobic chamber or jars with anaerobic gas packs. Ensure all manipulations are done quickly to minimize exposure to oxygen. Using loose screw caps and sterile butyl rubber stoppers can help retain anaerobic conditions.
What is the recommended method for preparing Bifidobacterium infantis cultures for genomic studies?
For genomic studies, Bifidobacterium infantis should be cultured to mid-log phase in an anaerobic environment. Harvest cells by centrifugation and extract DNA using a high-quality genomic DNA isolation kit. Ensuring high-purity DNA is crucial for downstream applications such as sequencing.
What are the specific steps for rehydrating lyophilized Bifidobacterium infantis?
Rehydrating lyophilized Bifidobacterium infantis involves adding the lyophilized pellet to a pre-warmed anaerobic medium, followed by gentle mixing. Incubate the rehydrated culture in an anaerobic environment at 37°C until the culture reaches the desired density, ensuring minimal oxygen exposure during the process.
What are the best practices for storing Bifidobacterium infantis to maintain its viability?
Store Bifidobacterium infantis at -80°C in a cryoprotectant such as glycerol or skim milk. Avoid repeated freeze-thaw cycles to prevent loss of viability. Aliquoting the culture into small volumes can help minimize thawing events.
How can the activity of Bifidobacterium infantis be assessed after storage?
To assess the activity of Bifidobacterium infantis after storage, revive the culture in an anaerobic medium and monitor growth parameters such as optical density and colony-forming units. Additionally, functional assays such as short-chain fatty acid production can be performed to confirm activity.
Exceptional Consistency in Research Bifidobacterium infantis Reuter from Creative Biolabs consistently delivers reliable results in our gut microbiota studies. Its stability under experimental conditions surpasses other strains, making it invaluable for our research.
Enhanced Immune Response Studies
This strain significantly enhances immune response studies, demonstrating superior modulation of immune markers. Bifidobacterium infantis Reuter has proven essential in understanding host-microbe interactions.
High Viability and Stability Bifidobacterium infantis Reuter maintains high viability and stability in anaerobic cultures, providing dependable results in our microbial fermentation research. Its performance is unmatched by other similar products.
Excellent for In Vitro Tests In vitro tests of immune system modulation have shown remarkable results with Bifidobacterium infantis Reuter. Its consistent performance in enhancing immune responses makes it a preferred choice in our lab.
Superior Gut Barrier Studies
Using Bifidobacterium infantis Reuter in gut barrier integrity studies has yielded significant findings. This strain's ability to improve intestinal barrier function is unparalleled, aiding in advanced research.
Click the button below to contact us or submit your feedback about this product.
